Cane Capital Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.37M Sell
10,009
-3,959
-28% -$559K 0.51% 48
2026
Q2
$2.05M Sell
13,968
-4,288
-23% -$777K 0.81% 29
2026
Q1
$2.69M Buy
18,256
+10,995
+151% +$1.79M 1.17% 23
2025
Q4
$1.42M Hold
7,261
– – 0.56% 36

Other funds holding ORCL

Cane Capital Partners's ORCL Position: Q3 2026 in Review

Cane Capital Partners reduced its Oracle (ORCL) stake by 28% in Q3 2026, selling an estimated $559K and leaving 10,009 shares worth $1.37M. The position accounts for 0.51% of the portfolio, ranked #48.

Cane Capital Partners first reported a position in ORCL in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.69M in Q1 2026. 3,453 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Cane Capital Partners held 10,009 shares of Oracle worth $1.37M as of Q3 2026.
  • Cane Capital Partners sold 3,959 Oracle shares in Q3 2026, an estimated $559K.
  • Oracle made up 0.51% of Cane Capital Partners's portfolio in Q3 2026, its #48 holding.
  • Cane Capital Partners first reported a position in Oracle in Q4 2025 and has held it in 4 quarters since.
  • Cane Capital Partners's Oracle position peaked at $2.69M in Q1 2026.
  • 3,453 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Cane Capital Partners's 13F filing for Q3 2026, filed 23 Oct 2026.